Chuanzhong Huang

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.

Cross-scale modeling reveals a TFRC-driven immunosuppressive macrophage niche in cervical cancer.

Journal: Frontiers in immunology

Published: May 05, 2026

Cancer-associated fibroblast-derived vascular endothelial growth factor a promotes gastric cancer organoid growth and chemotherapy resistance via paracrine signaling.

Cancer-associated fibroblast-derived vascular endothelial growth factor a promotes gastric cancer organoid growth and chemotherapy resistance via paracrine signaling.

Journal: Cellular signalling

Published: April 13, 2026

USP35 Acts as a Deubiquitinating Enzyme for ID3 to Promote Immune Escape in Colorectal Cancer.

USP35 Acts as a Deubiquitinating Enzyme for ID3 to Promote Immune Escape in Colorectal Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 27, 2025

Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer.

Activation of the NF-κB/ALDH1A1 signaling promotes non-mutational resistance to EGFR-TKIs in non-small cell lung cancer.

Journal: Oncogene

Published: August 10, 2025

ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion.

ID3 enhances PD-L1 expression by restructuring MYC to promote colorectal cancer immune evasion.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 10, 2025

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Journal: BMC cancer

Published: March 26, 2024

UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.

UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.

Journal: BMC cancer

Published: January 12, 2024

Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1.

Targeting Nuclear Receptor Coactivator SRC-1 Prevents Colorectal Cancer Immune Escape by Reducing Transcription and Protein Stability of PD-L1.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 20, 2023

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway.

EIF3B affects the invasion and metastasis of hepatocellular carcinoma cells via the TGFBI/MAPK/ERK pathway.

Journal: Annals of hepatology

Published: December 05, 2023

Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.

Abnormal variation and prognostic significance of circulating immune cells in patients with nasopharyngeal carcinoma treated with chemoradiotherapy: a prospective cohort study.

Journal: Translational cancer research

Published: October 31, 2023

Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study.

Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study.

Journal: Frontiers in cell and developmental biology

Published: October 10, 2023

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Journal: BMC cancer

Published: August 15, 2023

Showing 1-12 of 27

Last Updated: 09/26/2026